Acclinate has been selected as an awardee in the Maternal-fetal Immune Disorders Quickfire Challenge. The QuickFire Challenges are managed by Johnson & Johnson Innovation to help address today's significant healthcare challenges.
The challenge invited innovators to submit data-driven research methodologies, tools, or technologies that aim to understand better the manifestation of immune-mediated diseases of pregnancy impacting communities of color.
Read more about the challenge and announcement.
